If you have not already registered for Full Text Access to The Journal, then visit our registration page.


VOLUME 66   2005   NUMBER 11

Commentary

1349 Hurricane Katrina: A Physician's Whirlwind Course in Disaster Psychiatry. Shane Stephen Spicer
[PDF]

Original Articles

1351 The Epidemiology of Social Anxiety Disorder in the United States: Results From the National Epidemiologic Survey on Alcohol and Related Conditions. Bridget F. Grant, Deborah S. Hasin, Carlos Blanco, Frederick S. Stinson, S. Patricia Chou, Rise B. Goldstein, Deborah A. Dawson, Sharon Smith, Tulshi D. Saha, and Boji Huang
[Abstract] [PDF]

1362 Efficacy of Aripiprazole Against Hostility in Schizophrenia and Schizoaffective Disorder: Data From 5 Double-Blind Studies. Jan Volavka, Pal Czobor, Leslie Citrome, Robert D. McQuade, William H. Carson, Dusan Kostic, Sterling Hardy, and Ronald Marcus
[Abstract] [PDF]

1367 Clinical Characteristics and Psychiatric Comorbidity in Males With Exhibitionism. Jon E. Grant
[Abstract] [PDF]

1372 Treatment of the Polydipsia-Hyponatremia Syndrome With Urea. Anne Verhoeven, Wim Musch, and Guy Decaux
[Abstract] [PDF]

1376 Typical and Atypical Antipsychotics in Bipolar Depression. Keming Gao, Prashant Gajwani, Omar Elhaj, and Joseph R. Calabrese
[Abstract] [PDF]

1386 QTc Interval Measurement and Metabolic Parameters in Psychiatric Patients Taking Typical or Atypical Antipsychotic Drugs: A Preliminary Study. Paul Mackin and Allan H. Young
[Abstract] [PDF]

1392 Sequential Treatment of Mood and Anxiety Disorders. [CME] Giovanni A. Fava, Chiara Ruini, and Chiara Rafanelli
[Abstract] [PDF]

1401 The Selective GABA Reuptake Inhibitor Tiagabine for the Treatment of Generalized Anxiety Disorder: Results of a Placebo-Controlled Study. Mark H. Pollack, Peter P. Roy-Byrne, Michael Van Ameringen, Heather Snyder, Charles Brown, John Ondrasik, and Karl Rickels
[Abstract] [PDF]

1409 Residual Symptoms in Depressed Patients After Treatment With Fluoxetine or Reboxetine. J. Craig Nelson, Laura Portera, and Andrew C. Leon
[Abstract] [PDF]

1415 Cognitive Therapy and Exposure in Vivo Alone and in Combination With Fluvoxamine in Obsessive-Compulsive Disorder: A 5-Year Follow-Up. Patricia van Oppen, Anton J. L. M. van Balkom, Else de Haan, and Richard van Dyck
[Abstract] [PDF]

1423 Naturalistic, Retrospective Comparison Between Second-Generation Antipsychotics and Depot Neuroleptics in Patients Affected by Schizophrenia. Livio Marchiaro, Paola Rocca, Ferdinando LeNoci, Pierpaolo Longo, Cristiana Montemagni, Cristiana Rigazzi, and Filippo Bogetto
[Abstract] [PDF]

1432 Misdiagnosed Patients With Bipolar Disorder: Comorbidities, Treatment Patterns, and Direct Treatment Costs. Louis S. Matza, Krithika S. Rajagopalan, Christine L. Thompson, and Gregory de Lissovoy
[Abstract] [PDF]

1441 Safety and Efficacy of Escitalopram in the Long-Term Treatment of Generalized Anxiety Disorder. Jonathan R. T. Davidson, Anjana Bose, and Qin Wang
[Abstract] [PDF]

1447 Variables Associated With Alcohol, Drug, and Daily Smoking Cessation in Patients With Severe Mental Illnesses. [CME] Jose de Leon, Margaret T. Susce, Francisco J. Diaz, Diego M. Rendon, and Diana M. Velásquez
[Abstract] [PDF]

1456 Suicidal Ideation and Attempts in Bipolar I and II Disorders. Hanna Valtonen, Kirsi Suominen, Outi Mantere, Sami Leppämäki, Petri Arvilommi, and Erkki T. Isometsä
[Abstract] [PDF]

1463 Undiagnosed Hyperglycemia in Patients Treated With Atypical Antipsychotics. Michael J. Sernyak, Barbara Gulanski, and Robert Rosenheck
[Abstract] [PDF]

1468 Long-Term Weight Gain in Patients Treated With Open-Label Olanzapine in Combination With Fluoxetine for Major Depressive Disorder. Scott W. Andersen, David B. Clemow, and Sara A. Corya
[Abstract] [PDF]

Academic Highlights

1477 Untangling Depression and Anxiety: Clinical Challenges. [CME]
[PDF]

ASCP Corner

1488 Sexual Function and Dysfunction During Treatment With Psychotropic Medications. Richard Balon
[PDF]

Letters To the Editor

1490 Clozapine-Induced Pericarditis, Pericardial Tamponade, Polyserositis, and Rash. Moeen A. Bhatti, Janet Zander, and Elizabeth Reeve
[PDF]

1491 Applying Parsimony to "An African Patient With Ziprasidone Intolerance." Jeffrey L. Anders
[PDF]

  • Reply by Jakob Hein

1492 Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self-Injurious Behavior Associated With Borderline Personality Disorder. Christopher Pittenger, John H. Krystal, and Vladimir Coric
[PDF]

1493 Orally Disintegrating Antipsychotics May Promote Compliance and Adherence in Patients With Schizophrenia. Frank L. Tornatore
[PDF]

  • Reply by John M. Kane

1494 Reexamining Paroxetine and Cognitive-Behavioral Therapy in Postpartum Depression and Anxiety. Jennifer McClendon
[PDF]

  • Reply by Shaila Misri, Pratibha Reebye, Maria Corral, and Lisa Milis

Book Reviews 1496